Microbiome research has made similar promises as genomic research — the potential ability to cure chronic diseases and more — but Rob Knight from the University of California, San Diego, and the American Gut Project writes in Scientific American that microbiome research may be better poised to deliver. People's microbiomes, after all, are easier to change than their genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.